A Mechanistic Rationale for PDE-4 Inhibitors to Treat Residual Cognitive Deficits in Acquired Brain Injury

Patients with acquired brain injury (ABI) suffer from cognitive deficits that interfere significantly with their daily lives. These deficits are long-lasting and no treatment options are available. A better understanding of the mechanistic basis for these cognitive deficits is needed to develop nove...

Descripción completa

Detalles Bibliográficos
Autores principales: Schreiber, Rudy, Hollands, Romain, Blokland, Arjan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2020
Materias:
Neuropharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327948/
https://www.ncbi.nlm.nih.gov/pubmed/31660837
http://dx.doi.org/10.2174/1570159X17666191010103044

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7327948/
https://www.ncbi.nlm.nih.gov/pubmed/31660837
http://dx.doi.org/10.2174/1570159X17666191010103044

Ejemplares similares